Seasickness Susceptability and Vestibular Time Constant
NCT05640258 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67
Last updated 2022-12-14
Summary
Participants were selected from the military navy crewmembers prior to commencing of active sailing.
A vestibular time constant was calculated based on velocity step testing on a rotatory chair at baseline, 3 months and 6 month following active sailing duty.
A seasickness questionnaire (WIKER) was completed during follow-up visits. study participants were divided to three groups based on WIKER score - susceptible , non-susceptible and habituating. Vestibular time constant was compared between study groups.
Conditions
- Seasickness
Interventions
- DIAGNOSTIC_TEST
-
rotatory chair testing in a velocity step protocol.
Tc was evaluated by the rotational velocity step test using the OtoaccessTM interface (Interacoustics Nydiag 200, Middlefart, Denmark). Subjects were seated on the rotatory chair wearing videonystagmography goggles with their heads supported and tilted 30° forward, thus bringing the horizontal semicircular canals plane perpendicular to the axis of rotation. Standard videonystagmography techniques were employed to record eye-movements. Subsequent to eye movements' calibration, the chair was accelerated about the yaw axis at 30°/sec2 to a maximal velocity of 90°/sec, followed by rotation at a constant velocity. After 57 seconds of constant velocity rotation, the chair was decelerated to zero velocity at 30°/sec2. The described velocity step was conducted both clockwise and counter-clockwise, giving a total run time of 4 minutes.
Sponsors & Collaborators
-
Medical Corps, Israel Defense Force
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 20 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-09-18
- Primary Completion
- 2020-01-26
- Completion
- 2020-07-26
Countries
- Israel
Study Locations
More Related Trials
-
Motion Sickness on Astrolabe's Vessel
NCT02911402 ·Status: COMPLETED
-
Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey
NCT01378351 ·Status: TERMINATED
-
The Prevention and Treatment of Nausea Associated With Motion Sickness
NCT03986905 ·Status: COMPLETED ·Phase: PHASE3
-
Cortical Excitability in Cyclic Vomiting Syndrome
NCT05256160 ·Status: RECRUITING ·Phase: NA
-
Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness
NCT04184115 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects
NCT03988530 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness
NCT03755596 ·Status: COMPLETED ·Phase: PHASE4
-
Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms
NCT05611814 ·Status: COMPLETED ·Phase: NA
-
Meclizine Plasma Levels in Responders and Non-responders
NCT04482985 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
NCT05548270 ·Status: COMPLETED ·Phase: PHASE3
-
Applying Nutrient Drink Test in Understanding Pathophysiology of CVS
NCT03470181 ·Status: COMPLETED
-
Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer
NCT00020657 ·Status: COMPLETED ·Phase: PHASE3
-
Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
NCT04947423 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going Vessels
NCT03920644 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of TAK-951 in Participants With Cyclic Vomiting Syndrome (CVS)
NCT06768658 ·Status: TERMINATED ·Phase: PHASE1
-
Auricular Neurostimulation for Cyclic Vomiting Syndrome
NCT03434652 ·Status: COMPLETED ·Phase: NA
-
Ginger Control of Chemotherapy Induced Nausea and Vomiting
NCT00065221 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of TAK-105 in Healthy Adults
NCT04964258 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea
NCT01556932 ·Status: COMPLETED ·Phase: NA
-
Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers
NCT02177890 ·Status: COMPLETED ·Phase: NA
-
Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children
NCT03295760 ·Status: COMPLETED
-
Pharmacokinetics of Atropine Oral Gel
NCT05164367 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
NCT05852730 ·Status: RECRUITING ·Phase: PHASE2
-
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
NCT05886660 ·Status: RECRUITING ·Phase: PHASE2
-
Topical Capsaicin for Cyclical Vomiting
NCT03223350 ·Status: COMPLETED ·Phase: PHASE2